Atara Biotherapeutics, Inc. (ATRA)
NASDAQ: ATRA · Real-Time Price · USD
5.17
+0.44 (9.30%)
At close: Apr 1, 2026, 4:00 PM EDT
5.23
+0.06 (1.16%)
After-hours: Apr 1, 2026, 7:46 PM EDT

Atara Biotherapeutics Revenue

In the year 2025, Atara Biotherapeutics had annual revenue of $120.77M, down -6.33%. Atara Biotherapeutics had revenue of $1.60M in the quarter ending December 31, 2025, a decrease of -95.13%.

Revenue (ttm)
$120.77M
Revenue Growth
-6.33%
P/S Ratio
0.35
Revenue / Employee
$8,626,571
Employees
14
Market Cap
42.28M

Revenue Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 2025120.77M-8.17M-6.33%
Dec 31, 2024128.94M120.37M1,404.02%
Dec 31, 20238.57M-55.00M-86.51%
Dec 31, 202263.57M43.23M212.55%
Dec 31, 202120.34M--
Dec 31, 2020 Pro Pro Pro
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro